A monoclonal antibody that binds within the Sema domain of the alpha-chain of human c-Met. The antibody comprises the light chain CDRs defined by SEQ ID NOs 53, 54 and 56 and the heavy chain CDRs defined by SEQ ID NOs 65, 68 and 69. The antibody inhibits the activity of c-Met and can be used in the treatment of cancer.